First published in Pulmonary Pharmacology & Therapeutics on 2015 Feb.Pulm Pharmacol Ther. 2015 Feb;30:80-6. doi: 10.1016/j.pupt.2014.12.001. Epub 2014 Dec 19...
Read Article
This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the treatment of serious Pseudomonas aeruginosa infections.